Takisha Pharma Private Limited
About Takisha Pharma Private Limited
Data last updated:
Takisha Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 09 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2018PTC309134. Its GSTIN is 09AAGCT7606J1ZY (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Zameer Ul Haque Ansari (Whole-Time Director) and Soofia Baby (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No. 3 Bhim Shakti Pl Lokhande Marg Chembur, Mumbai, Maharashtra, India – 400089.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.09 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹14,780 (net margin 0.9%) and EBITDA of ₹32,361 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 4% over five years.
Company details
Contact details
Takisha Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressRoom No. 3 Bhim Shakti Pl Lokhande Marg Chembur, Mumbai, Maharashtra, India – 400089
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Takisha Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Takisha Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Takisha Pharma Private Limited, buy the company report.
Financials of Takisha Pharma Private Limited
FY 2025 filings availableTakisha Pharma Private Limited reported revenue of ₹17.09 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 8% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32,361 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14,780 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Takisha Pharma Private Limited, buy the company report.
Board of directors of Takisha Pharma Private Limited
Takisha Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Zameer Ul Haque Ansari | Whole-Time Director | 09 May 2018 | 8 Years 5 Months | Current |
| Soofia Baby | Whole-Time Director | 09 May 2018 | 8 Years 5 Months | Current |
Peer comparison
Takisha Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rikhav Financial Services Private Limited | ₹17.12 Lakh (FY 2024) | 17.0% | Mumbai, Maharashtra, India | |||
| Vexia Bio Science Private Limited | ₹17.11 Lakh (FY 2024) | 147.0% | Delhi, India | |||
| BFS Infra and Overseas Private Limited | ₹17.11 Lakh (FY 2025) | 91.0% | Kolkata, West Bengal, India | |||
| TGF Glass and Aluminium (I) Private Limited | ₹17.11 Lakh (FY 2025) | -14.0% | Vashi, Maharashtra, India | |||
| Sthitpragya Enterprises Private Limited | ₹17.1 Lakh (FY 2024) | -65.0% | Bhubaneswar, Odisha, India | |||
| Takisha Pharma Private Limitedthis company | ₹17.09 Lakh (FY 2025) | ₹14,780 | 0.9% | 8.0% | Mumbai, Maharashtra, India | |
| Falah International Private Limited | ₹17.09 Lakh (FY 2025) | 955.0% | Jalalpore, Gujarat, India | |||
| Orcheed Medical Equipment Services Private Limited | ₹17.09 Lakh (FY 2024) | -18.0% | Lucknow, Uttar Pradesh, India | |||
| Solnit Products Private Limited | ₹17.07 Lakh (FY 2025) | Amreli, Gujarat, India | ||||
| Bolsron Pharmaceuticals Private Limited | ₹17.07 Lakh (FY 2025) | -8.0% | Jaipur, Rajasthan, India | |||
| Rakesh Vyapaar Private Limited | ₹17.07 Lakh (FY 2025) | -3.0% | West Bengal, India |
To see the full peer comparison of Takisha Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Takisha Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Takisha Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Takisha Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCT7606J1ZY | Uttar Pradesh | Active | 09 Jun 2022 |
To see the full GST registrations and return filing status of Takisha Pharma Private Limited, buy the company report.
Recent activity
Takisha Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Soofia Baby was appointed as Whole-Time Director on 09 May 2018.
Frequently asked questions
Takisha Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 09 May 2018 (8+ years old) and is registered under CIN U51909MH2018PTC309134.
Takisha Pharma has 2 current directors:
- Zameer Ul Haque Ansari - Whole-Time Director
- Soofia Baby - Whole-Time Director
The latest financial statements of Takisha Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Takisha Pharma is 09AAGCT7606J1ZY, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Takisha Pharma is U51909MH2018PTC309134. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Takisha Pharma was incorporated on 09 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Takisha Pharma by revenue are Rikhav Financial Services Private Limited, Vexia Bio Science Private Limited, BFS Infra and Overseas Private Limited, TGF Glass and Aluminium (I) Private Limited, Sthitpragya Enterprises Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Soofia Baby was appointed as Whole-Time Director on 09 May 2018. Zameer Ul Haque Ansari was appointed as Whole-Time Director on 09 May 2018.
The registered office of Takisha Pharma is at Room No. 3 Bhim Shakti Pl Lokhande Marg Chembur, Mumbai, Maharashtra, India – 400089.
Takisha Pharma operates in the trading industry, in the specialty segment.
Takisha Pharma can be reached at its registered office: Room No. 3 Bhim Shakti Pl Lokhande Marg Chembur, Mumbai, Maharashtra, India – 400089.